About Trice Medical
Trice Medical is a company based in King Of Prussia (United States) founded in 2012. Trice Medical has raised $85.47 million across 12 funding rounds from investors including Bioventus, Smith & Nephew and Safeguard Scientifics. Trice Medical has completed 2 acquisitions, including SegWAY Orthopaedics and Tenex Health. Trice Medical offers products and services including TX MicroTip for Soft Tissue, TX MicroTip for Hard Tissue, Tenex Diabetic Foot Ulcer Application, Seg-WAY Ligament Release Systems, and mi-eye 3 Needlescope.
- Headquarter King Of Prussia, United States
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Trice Medical Inc
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$85.47 M (USD)
in 12 rounds
-
Latest Funding Round
$10.5 M (USD), Series D
Aug 04, 2023
-
Investors
Bioventus
& 7 more
-
Employee Count
Not available
-
Investments & Acquisitions
SegWAY Orthopaedics
& 1 more
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Trice Medical
Trice Medical offers a comprehensive portfolio of products and services, including TX MicroTip for Soft Tissue, TX MicroTip for Hard Tissue, Tenex Diabetic Foot Ulcer Application, Seg-WAY Ligament Release Systems, and mi-eye 3 Needlescope.
Device for removing soft tissue in tendinopathy treatments.
Tool for bone spur and calcification removal procedures.
Application for treating wounds and foot ulcers effectively.
Systems for carpal tunnel and cubital tunnel releases.
Needlescope for small joint arthroscopy and diagnostics.
People of Trice Medical
Unlock access to complete
Unlock access to complete
Funding Insights of Trice Medical
Trice Medical has successfully raised a total of $85.47M across 12 strategic funding rounds. The most recent funding activity was a Series D round of $10.5 million completed in August 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Trice Medical
Trice Medical has secured backing from 8 investors, including institutional and venture fund investors. Prominent investors backing the company include Bioventus, Smith & Nephew and Safeguard Scientifics.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital firm investing in early and growth stage companies
|
Locked | Locked | Locked | |
|
Investments are focused on tech and life sciences startups.
|
Locked | Locked | Locked | |
|
Healthtech startups are funded by BioStar Capital's venture capital efforts.
|
Locked | Locked | Locked |
Investor details for Trice Medical
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Trice Medical
Trice Medical has strategically engaged in corporate development activities, having acquired 2 companies. Notable acquisitions include SegWAY Orthopaedics and Tenex Health.
Investment portfolio details for Trice Medical
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Minimally invasive therapies are provided for diseased tendon removal.
|
Locked | Locked | 2009 | Locked | |
|
Endoscopic guide systems for orthopedic extremity procedures are developed.
|
Locked | Locked | 2007 | Locked |
Complete acquisition details for Trice Medical
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - Trice Medical
Detailed financials for Trice Medical
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Trice Medical Comparisons
Peer comparison for Trice Medical
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Trice Medical
Detailed competitors of Trice Medical
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Trice Medical
Complete news archive for Trice Medical
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Trice Medical
Trice Medical was founded in 2012.
Trice Medical is headquartered in King Of Prussia, United States. It is registered at King Of Prussia, Pennsylvania, United States.
Mike Steen is the current CEO of Trice Medical.
Trice Medical is a funded company, having raised a total of $85.47M across 12 funding rounds to date.
Trice Medical was founded in 2012 and is headquartered in King of Prussia, United States. Needle-based diagnostic and therapeutic technologies for orthopedics are provided by the company. The FDA-approved Mi-eye product is a disposable visualization device that incorporates a camera and light source into a standard 14-gauge needle. Diagnostic arthroscopies are enabled in office settings through this technology.
Trice Medical offers TX MicroTip for Soft Tissue, TX MicroTip for Hard Tissue, Tenex Diabetic Foot Ulcer Application, Seg-WAY Ligament Release Systems, and mi-eye 3 Needlescope.
Trice Medical has made 2 acquisitions, including SegWAY Orthopaedics, and Tenex Health.
Trice Medical has 8 investors. Key investors include Bioventus, Smith & Nephew, Safeguard Scientifics, Health Quest Capital, and MERS.